hims compounded glp-1 Novo Nordisk calls out dangers of GLP-1s in new ad Hims? Hers? It's Novo Nordisk's

Last year, drugs for metabolic disorders were among the top earners for Big Pharma companies as a class

Se debe buscar atencin mdica urgente si hay vmitos persistentes, dolor abdominal intenso o signos de deshidratacin severa

Medically reviewed by Dr Kathryn Basford Last reviewed: 02 Jun 2026 Mounjaro, Wegovy, and Ozempic are all injection medications that can be used for weight loss, although only Mounjaro and Wegovy are licensed for weight loss in the UK

Indeed, it has been estimated that just 10-15% of the secreted GLP-1(7-36) NH2 reaches the systemic circulation (117), with some authors reporting meager peripheral meal-induced changes in both healthy and diabetic people (118)

Reduced tolerance, increased nausea after fewer drinks, and a general decrease in the desire to drink are commonly reported

And so itll be interesting to see if the agency restricts their ability to access these drugs and how America will respond. State-level concern The debate over compounded weight-loss drugs is taking place in statehouses around the country, including Indiana, California, Florida, Mississippi, Ohio and Washington